Luminous bags $23.5m in series B:
This article was originally published in Clinica
Executive Summary
Luminous Medical is one step closer to taking its automated blood glucose monitor to market, following the closing of a $23.5m series B financing. The round was led by Adams Street Partners - new investors RiverVest Venture Partners and Finistere Ventures and existing Luminous shareholders also provided the financing. Luminous will use the proceeds to complete development of its technology and enter commercialisation phase. The company's monitor is designed to provide frequent glucose measurements automatically.